BPC 157 Healthy Balance Market BPC 157 Benefits: Heal & Thrive in 2025 BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Exciting News from Vidalia Immediate + Primary Care! We're thrilled to announce that we're now offering BPC 157 & TB 500 The Blend Peptide! When used together, these two peptides Save this date: July 23 24, 2026. That is when the FDA Pharmacy Compounding Advisory Committee (PCAC) meets to vote on the legal fate of 7 major peptides. On the table: BPC 157